While exact figures vary across different reports, the market size is estimated to be valued at approximately USD 368.6 million in 2025, with projections reaching up to USD 5.145 billion by 2033, depending on the source.

When it comes to building materials, safety and reliability are never negotiable. Every structure—whether it is residential, commercial, or industrial—depends heavily on the quality and standardization of the materials used.

Large pharmaceutical companies, alongside biotech start-ups, are investing heavily in scalable manufacturing technologies, such as automated cell processing and advanced viral vector production, to address the high demand.